Literature DB >> 9664978

Results of orthotopic liver transplantation for liver cirrhosis in the presence of incidental and/or undetected hepatocellular carcinoma and tumour characteristics.

M Adham1, E Oussoultzoglou, C Ducerf, B Bancel, T Bizollon, A Rode, N Berthoux, E De La Roche, J Baulieux.   

Abstract

Orthotopic liver transplantation (OLT) for liver cirrhosis in the presence of hepatocellular carcinoma (HCC) is based on tumour number and size. The high incidence of undetected HCC before OLT has been reported previously. The object of this work to report the results of OLT for liver cirrhosis in the presence of incidental and/or undetected HCC and tumour characteristics. From 1985 to 1996, 334 patients received OLT. Two groups of patients were studied; group 1 (G1) where HCC was diagnosed on radiological examination before OLT (n = 13, mean age 53.8 +/- 8.1 years), and group 2 (G2), where HCC was diagnosed on pathological review (n = 13, mean age 53.3 +/- 6.1 years). Indications for OLT were (G1/G2) hepatitis C = 6/8, hepatitis B = 5/2, alcoholic = 2/3. There was no statistically significant difference in alpha-foetoprotein levels between both groups. Pathological review showed 26 and 30 HCC with a mean size of 1.6 +/- 0.8 and 1.6 +/- 1.2 cm (P > 0.05) in G1 and G2, respectively. Tumour stagings were (G1/G2) stage I = 6/2, stage II = 4/6, stage III = 2/3, stage IVa = 1/2. We had two (G2) hospital and three (G1) later mortalities; none had HCC recurrence. The other patients are alive and recurrence free. Reinforced immunosuppression related to acute or chronic rejection treatment was not associated with HCC recurrence. The 5-year actuarial survival rates were 76% for G1 and 85% for G2 (P > 0.05). Our study revealed that long-term survival can be achieved with liver transplantation in the presence of HCC in carefully selected patients.

Entities:  

Mesh:

Year:  1998        PMID: 9664978     DOI: 10.1007/s001470050460

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  4 in total

1.  Radiofrequency and microwave ablation in combination with transarterial chemoembolization induce equivalent histopathologic coagulation necrosis in hepatocellular carcinoma patients bridged to liver transplantation.

Authors:  Raj Vasnani; Michael Ginsburg; Osman Ahmed; Taral Doshi; John Hart; Helen Te; Thuong Gustav Van Ha
Journal:  Hepatobiliary Surg Nutr       Date:  2016-06       Impact factor: 7.293

2.  Preoperative embolization.

Authors:  William S Rilling; Gene W Chen
Journal:  Semin Intervent Radiol       Date:  2004-03       Impact factor: 1.513

3.  Analysis of tumor characteristics and survival in liver transplant recipients with incidentally diagnosed hepatocellular carcinoma.

Authors:  C S Cho; S J Knechtle; D M Heisey; M Hermina; M Armbrust; A M D'Alessandro; A I Musat; M Kalayoglu
Journal:  J Gastrointest Surg       Date:  2001 Nov-Dec       Impact factor: 3.452

4.  Clinicopathologic features of hepatic neoplasms in explanted livers: a single institution experience.

Authors:  Walid Mourad; Hatem Khalaf; Asma Tulbah; Mohammed Al Omari; Hadeel Al Mana; Mohamed Neimatallah
Journal:  Ann Saudi Med       Date:  2007 Nov-Dec       Impact factor: 1.526

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.